Federal Register / Vol. 62, No. 32 / Tuesday, February 18, 1997 / Notices 7245

and program priorities specified

elsewhere in this notice.

Funding of Approved Applications

Final funding decisions for SPRANS

research and training grants are the

responsibility of the Director, MCHB. In

considering scores for the ranking of

approved applications for funding,

preferences may be exercised for groups

of applications, e.g., applications from

geographical areas without previously

funded projects in particular category

vs. applications from with previously

funded projects. Within any category of

approved projects, the score of an

individual project may be favorably

adjusted if the project addresses specific

priorities identified in this notice. In

addition, special consideration in

assigning scores may be given by

reviewers to individual applications

that address areas identified in this

notice as meriting special consideration.

Executive Order 12372

The MCH Federal set-aside program

has been determined to be a program

which is not subject to the provisions of

Executive Order 12372 concerning

intergovernmental review of Federal

programs.

The OMB Catalog of Federal Domestic

Assistance number is 93.110.

Dated: February 6, 1997.

Ciro V. Sumaya,

Administrator.

[FR Doc. 97–3892 Filed 2–14–97; 8:45 am]

BILLING CODE 4160–15–P

National Institutes of Health; National

Cancer Institute

Notice of Meeting of the National

Cancer Advisory Board and its

Subcommittees Pursuant to Public Law

92–463, notice is hereby given of the

meeting of the National Cancer

Advisory Board, National Cancer

Institute, and its Subcommittees on

February 24–26, 1997. The meetings of

the Board and its Subcommittees will be

open to the public as indicated below.

Attendance by the public will be limited

to space available.

A portion of the Board meeting will

be closed to the public in accordance

with the provisions set forth in secs.

552b(c)(4), 552b(c)(6), and 552(c)(9)(B),

Title 5, U.S.C. and sec. 10(d) of Public

Law 92–463, for the review, discussion

and evaluation of individual grant

applications and for discussion of issues

pertaining to programmatic areas and/or

NCI personnel. These applications and

discussions could reveal confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning the

individuals associated with the

applications or programs, the disclosure

of which would constitute a clearly

unwarranted invasion of personal

privacy and premature disclosure of

recommendations which would inhibit

the final outcome and subsequent

implementation of recommendations.

The Committee Management Office,

National Cancer Institute, National

Institutes of Health, Executive Plaza

North, Room 630E, 6130 Executive

Boulevard, MSC 7410, Rockville,

Maryland 20892–7410, (301) 496–5708

will provide summaries of the meetings

and rosters of the Board members, upon

request.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Ms. Cynthia Morgan, Committee

Management Specialist, at (301) 496–

5708 in advance of the meeting.

Name of Committee: Ad Hoc

Subcommittee on Policy and Advocacy.

Contact Person: Dr. Marvin R. Kalt,

Executive Secretary, National Cancer

Institute, NIH, Executive Plaza North, Room

600, 6130 Executive Blvd., MSC 7405,

Bethesda, MD 20892–7405, (301) 496–5147.

Date of Meeting: February 24, 1997.

Place of Meeting: Hyatt Regency Bethesda,

One Bethesda Metro Center, Bethesda, MD

20814.

Open: 7:00 pm to 9:00 pm.

Agenda: To discuss the role of the NCAB

in advocacy activities and in advising NCI on

extramural and intramural policy.

Name of Committee: Subcommittee on

Cancer Centers.

Contact Person: Dr. Brian Kimes, Executive

Secretary, National Cancer Institute, NIH,

Executive Plaza North, Room 502, 6130

Executive Blvd., MSC 7383, Bethesda, MD

20892–7383, (301) 496–8537.

Date of Meeting: February 24, 1997.

Place of Meeting: Hyatt Regency Bethesda,

One Bethesda Metro Center, Bethesda, MD

20814.

Open: 7:00 pm to 9:00 pm.

Agenda: To discuss new Cancer Centers

guidelines.

Name of Committee: Subcommittee on

Planning and Budget.

Contact Person: Ms. Cherie Nichols,

Executive Secretary, National Cancer

Institute, NIH, 7550 Wisconsin Avenue,

Room 312, MSC 9010, Bethesda, MD 20892–

9010, (301) 496–5515.

Date of Meeting: February 25, 1997.

Place of Meeting: Conference Room 10,

Building 31C, National Institutes of Health,

9000 Rockville Pike, Bethesda, MD 20892.

Open: 1:15 pm to 2:30 pm.

Agenda: To discuss the NCI Budget and

various planning issues.

Name of Committee: Subcommittee on

Special Actions for Grants.

Contact Person: Dr. Marvin R. Kalt,

Executive Secretary, National Cancer

Institute, NIH, Executive Plaza North, Room

600, 6130 Executive Blvd., MSC 7405,

Bethesda, MD 20892–7405, (301) 496–5147.

Date of Meeting: February 25, 1997.

Closed: 3:45 to approximately 5:00 pm.

Place of Meeting: Conference Room 10,

Building 31C, National Institutes of Health,

9000 Rockville Pike, Bethesda, MD 20892

Agenda: For review and discussion of

individual grant applications.

Name of Committee: National Cancer

Advisory Board.

Contact Person: Dr. Marvin R. Kalt,

Executive Secretary, National Cancer

Institute, NIH, Executive Plaza North, Room

600, 6130 Executive Blvd., MSC 7405,

Bethesda, MD 20892–7405, (301) 496–5147.

Dates of Meeting: February 25–26, 1997.

Place of Meeting: Conference Room 10,

Building 31C, National Institutes of Health,

9000 Rockville Pike, Bethesda, MD 20892.

Open: February 25—8:30 am to

approximately 1:15 pm; February 25—2:30

pm to approximately 3:45 pm; February 26—

8:30 am to adjournment.

Agenda: Report of the Director, National

Cancer Institute; Reports from the

Association of Community Cancer Centers

and American Association for Cancer

Research; Subcommittee Reports including

Global Programs at Cancer Centers and

Cancer Center Guidelines; Report of the

Director, Division of Research Grants;

Discussion of Mammography Guidelines;

Discussion of President’s Cancer Panel

Report on Managed Health Care; and other

Council business.

Closed: February 25—5:00 pm to

adjournment.

Agenda: For review and discussion of grant

applications and extramural/intramural

programmatic and personnel policies.

This notice is being published less

than 15 days prior to the meeting due

to the urgent need to meet timing

limitations imposed by the review and

funding cycle.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control.)

Dated: February 10, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–3937 Filed 2–14–97; 8:45 am]

BILLING CODE 4140–01–M

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following meeting

of the National Cancer Institute Initial

Review Group:

Agenda/Purpose: To review and evaluate

grant applications.